CAS: 1354039-86-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ACT 335827 REF: 3D-EEC03986CAS: 1354039-86-3 | Min. 95% | 232,00 €~1.855,00 € | Mar 28 Ene 25 |
 | ACT 335827 REF: TM-T21850CAS: 1354039-86-3 | - - - | 1.040,00 €~4.194,00 € | Mar 18 Feb 25 |
ACT 335827
CAS:1354039-86-3
ACT 335827 is a drug that is effective in the treatment of hypertension. It has …
Fórmula:
C31H38N2O5
Pureza:
Min. 95%
Peso molecular:
518.64 g/mol
Ref: 3D-EEC03986
| 1mg | 232,00 € | ||
| 2mg | 364,00 € | ||
| 5mg | 647,00 € | ||
| 10mg | 924,00 € | ||
| 25mg | 1.855,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Enero de 2025
ACT 335827
CAS:1354039-86-3
ACT-335827: oral, brain-penetrant OXR1 selective antagonist; IC50: 6 nM (OXR1), 417 nM (OXR2); for neurological …
Fórmula:
C31H38N2O5
Forma y color:
Solid
Peso molecular:
518.64
Ref: TM-T21850
| 10mg | 1.040,00 € | ||
| 50mg | 4.194,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
